Literature DB >> 7299123

Cyclophosphamide pretreatment induces eosinophilia to nonparasite antigens.

M A Vadas.   

Abstract

Eosinophilia is usually regarded as a T cell-dependent hemopoietic response, although in most instances of immune responses by T cells there is no accompanying eosinophilia. BALB/c mice immunized with keyhole limpet hemocyanin (KLH) in complete Freund's adjuvant (CFA) were found not to develop eosinophilia, whereas pretreatment of such mice with 150 mg/kg cyclophosphamide (CY) induced marked eosinophilia in the blood (1000 to 3000/mm3) and bone marrow. CY as well as CY and KLH in CFA cause a leukocytosis and neutrophilia, but significant eosinophilia was seen only in mice receiving both CY and KLH-CFA. The eosinophilic response depended on the dose of CY and peaked 13 days after immunization, and was preceded by a bone marrow eosinophilia that peaked 8 days after immunization. No eosinophilia occurred in BALB/c nu/nu mice after CY and KLH-CFA but did occur in the nu/+ littermates. This model in mice of eosinophilia in response to CY followed by a nonparasite antigen should be useful in the analysis of T cell signals that might regulate eosinophilia.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7299123

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  9 in total

1.  Genetic control of eosinophilia. Analysis of production and response to eosinophil-differentiating factor in strains of mice infected with Trichinella spiralis.

Authors:  D A Lammas; L A Mitchell; D Wakelin
Journal:  Clin Exp Immunol       Date:  1989-07       Impact factor: 4.330

Review 2.  Eosinophils as effector cells in immunity and hypersensitivity disorders.

Authors:  A B Kay
Journal:  Clin Exp Immunol       Date:  1985-10       Impact factor: 4.330

Review 3.  New properties and roles for eosinophils in disease: discussion paper.

Authors:  C J Spry
Journal:  J R Soc Med       Date:  1985-10       Impact factor: 5.344

4.  Synthesis of {alpha}(1,3) fucosyltransferases IV- and VII-dependent eosinophil selectin ligand and recruitment to the skin.

Authors:  Takahiro Satoh; Yasumasa Kanai; Ming-Hua Wu; Hiroo Yokozeki; Reiji Kannagi; John B Lowe; Kiyoshi Nishioka
Journal:  Am J Pathol       Date:  2005-09       Impact factor: 4.307

5.  Interleukin-5 is necessary for eosinophilia induced by cyclophosphamide in immunized mice.

Authors:  H H Mu; R Penny; W A Sewell
Journal:  Immunology       Date:  1993-07       Impact factor: 7.397

6.  Evidence for the control of eosinophilia by the major histocompatibility complex in mice.

Authors:  W A Sewell; M A Vadas
Journal:  Immunogenetics       Date:  1983       Impact factor: 2.846

7.  Immunosuppressive activity and toxicity of cyclosporin A in rats pretreated with high dose cyclophosphamide.

Authors:  P A Brown; A W Thomson; P H Whiting; R J Davidson; J G Simpson
Journal:  Agents Actions       Date:  1985-10

8.  Cyclophosphamide-induced eosinophilia in the rat: concomitant changes in T-cell subsets, B cells and large granular lymphocytes within lymphoid tissues.

Authors:  A W Thomson; I H Mathie; H F Sewell
Journal:  Immunology       Date:  1987-03       Impact factor: 7.397

9.  Genetic control of eosinophilia. Mouse strain variation in response to antigens of parasite origin.

Authors:  D Wakelin; A M Donachie
Journal:  Clin Exp Immunol       Date:  1983-02       Impact factor: 4.330

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.